These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

699 related items for PubMed ID: 12598893

  • 1. Suppression of experimental autoimmune encephalomyelitis by selective blockade of encephalitogenic T-cell infiltration of the central nervous system.
    Yan SS, Wu ZY, Zhang HP, Furtado G, Chen X, Yan SF, Schmidt AM, Brown C, Stern A, LaFaille J, Chess L, Stern DM, Jiang H.
    Nat Med; 2003 Mar; 9(3):287-93. PubMed ID: 12598893
    [Abstract] [Full Text] [Related]

  • 2. Experimental allergic encephalomyelitis. T cell trafficking to the central nervous system in a resistant Thy-1 congenic mouse strain.
    Skundric DS, Huston K, Shaw M, Tse HY, Raine CS.
    Lab Invest; 1994 Nov; 71(5):671-9. PubMed ID: 7526038
    [Abstract] [Full Text] [Related]

  • 3. Preferential distribution of V beta 8.2-positive T cells in the central nervous system of rats with myelin basic protein-induced autoimmune encephalomyelitis.
    Tsuchida M, Matsumoto Y, Hirahara H, Hanawa H, Tomiyama K, Abo T.
    Eur J Immunol; 1993 Oct; 23(10):2399-406. PubMed ID: 7691605
    [Abstract] [Full Text] [Related]

  • 4. Initiation and regulation of CNS autoimmunity.
    Goverman J, Brabb T, Paez A, Harrington C, von Dassow P.
    Crit Rev Immunol; 1997 Oct; 17(5-6):469-80. PubMed ID: 9419434
    [Abstract] [Full Text] [Related]

  • 5. Chronic experimental autoimmune encephalomyelitis induced by the 89-101 myelin basic protein peptide in B10RIII (H-2r) mice.
    Jansson L, Olsson T, Höjeberg B, Holmdahl R.
    Eur J Immunol; 1991 Mar; 21(3):693-9. PubMed ID: 1707002
    [Abstract] [Full Text] [Related]

  • 6. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
    Matejuk A, Buenafe AC, Dwyer J, Ito A, Silverman M, Zamora A, Subramanian S, Vandenbark AA, Offner H.
    J Neurosci Res; 2003 Jan 01; 71(1):89-103. PubMed ID: 12478617
    [Abstract] [Full Text] [Related]

  • 7. Tumor necrosis factor blockade in actively induced experimental autoimmune encephalomyelitis prevents clinical disease despite activated T cell infiltration to the central nervous system.
    Körner H, Lemckert FA, Chaudhri G, Etteldorf S, Sedgwick JD.
    Eur J Immunol; 1997 Aug 01; 27(8):1973-81. PubMed ID: 9295034
    [Abstract] [Full Text] [Related]

  • 8. Experimental autoimmune encephalomyelitis: the antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system.
    Berger T, Weerth S, Kojima K, Linington C, Wekerle H, Lassmann H.
    Lab Invest; 1997 Mar 01; 76(3):355-64. PubMed ID: 9121118
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis of V beta 8.2+ T lymphocytes in the spinal cord during recovery from experimental autoimmune encephalomyelitis induced in Lewis rats by inoculation with myelin basic protein.
    McCombe PA, Nickson I, Tabi Z, Pender MP.
    J Neurol Sci; 1996 Jul 01; 139(1):1-6. PubMed ID: 8836965
    [Abstract] [Full Text] [Related]

  • 10. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger L.
    Nat Genet; 1999 Nov 01; 23(3):343-7. PubMed ID: 10610182
    [Abstract] [Full Text] [Related]

  • 11. Epicutaneous (EC) immunization with myelin basic protein (MBP) induces TCRalphabeta+ CD4+ CD8+ double positive suppressor cells that protect from experimental autoimmune encephalomyelitis (EAE).
    Tutaj M, Szczepanik M.
    J Autoimmun; 2007 Jun 01; 28(4):208-15. PubMed ID: 17442539
    [Abstract] [Full Text] [Related]

  • 12. Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis.
    Brabb T, Goldrath AW, von Dassow P, Paez A, Liggitt HD, Goverman J.
    J Immunol; 1997 Jul 01; 159(1):497-507. PubMed ID: 9200491
    [Abstract] [Full Text] [Related]

  • 13. Apoptotic elimination of V beta 8.2+ cells from the central nervous system during recovery from experimental autoimmune encephalomyelitis induced by the passive transfer of V beta 8.2+ encephalitogenic T cells.
    Tabi Z, McCombe PA, Pender MP.
    Eur J Immunol; 1994 Nov 01; 24(11):2609-17. PubMed ID: 7957554
    [Abstract] [Full Text] [Related]

  • 14. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
    Meeson AP, Piddlesden S, Morgan BP, Reynolds R.
    Exp Neurol; 1994 Oct 01; 129(2):299-310. PubMed ID: 7525334
    [Abstract] [Full Text] [Related]

  • 15. Intrathecal administration of neutralizing antibody against Fas ligand suppresses the progression of experimental autoimmune encephalomyelitis.
    Okuda Y, Sakoda S, Fujimura H, Nagata S, Yanagihara T, Bernard CC.
    Biochem Biophys Res Commun; 2000 Aug 18; 275(1):164-8. PubMed ID: 10944459
    [Abstract] [Full Text] [Related]

  • 16. CD62L is required for the priming of encephalitogenic T cells but does not play a major role in the effector phase of experimental autoimmune encephalomyelitis.
    Li O, Liu JQ, Zhang H, Zheng P, Liu Y, Bai XF.
    Scand J Immunol; 2006 Aug 18; 64(2):117-24. PubMed ID: 16867156
    [Abstract] [Full Text] [Related]

  • 17. An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis.
    Karpus WJ, Lukacs NW, McRae BL, Strieter RM, Kunkel SL, Miller SD.
    J Immunol; 1995 Nov 15; 155(10):5003-10. PubMed ID: 7594507
    [Abstract] [Full Text] [Related]

  • 18. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues.
    Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martínez-A C, Varona R.
    Eur J Immunol; 2009 Jun 15; 39(6):1671-81. PubMed ID: 19499521
    [Abstract] [Full Text] [Related]

  • 19. Limited repertoire of HLA-DRB1*0401-restricted MBP111-129-specific T cells in HLA-DRB1*0401 Tg mice and their pathogenic potential.
    Huh J, Yao K, Quigley L, Ludwin SK, McFarland HF, Muraro PA, Martin R, Ito K.
    J Neuroimmunol; 2004 Jun 15; 151(1-2):94-102. PubMed ID: 15145608
    [Abstract] [Full Text] [Related]

  • 20. What transgenic and knockout mouse models teach us about experimental autoimmune encephalomyelitis.
    Fazekas G, Tabira T.
    Rev Immunogenet; 2000 Jun 15; 2(1):115-32. PubMed ID: 11324684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.